Aytu BioPharma, Inc. (LON:0A8M)
London · Delayed Price · Currency is GBP · Price in USD 2.200
+0.520 (30.95%)
At close: May 16, 2025
Aytu BioPharma Market Cap
Aytu BioPharma has a market cap or net worth of 16.49 million as of November 5, 2025. Its market cap has increased by 56.24% in one year.
Market Cap
16.49M
Enterprise Value
10.35M
Revenue
48.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.20
Market Cap Chart
Since April 22, 2015, Aytu BioPharma's market cap has decreased from 48.94M to 16.49M, a decrease of -66.30%. That is a compound annual growth rate of -9.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 16.49M | 97.53% |
| Dec 31, 2024 | 8.35M | -32.73% |
| Dec 29, 2023 | 12.41M | 26.76% |
| Dec 30, 2022 | 9.79M | -65.10% |
| Dec 31, 2021 | 28.06M | -64.15% |
| Dec 31, 2020 | 78.28M | 414.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.27B |
| HSBC Holdings | 184.59B |
| Shell | 164.07B |
| Unilever | 115.32B |
| Rolls-Royce Holdings | 96.56B |
| Rio Tinto Group | 90.02B |
| British American Tobacco p.l.c. | 87.25B |
| GSK plc | 70.63B |